| Name: | Budesonide EP impurity E |
| Catalogue No. | VL34004 |
| CAS No. | 131918-64-4 |
| Molecular Formula | C25H32O6 |
| Molecular Weight | 428.52 |
| Status | In-stock |
| IUPAC Name | (16α,17-[butylidenebis(oxy)]-11β,21-dihydroxypregna-1,4,14-triene-3,20-dione) |
| Synonyms | 14,15-Dehydro Budesonide / Budesonide Related Compound E |
| Appearance | Off White powder |
| Description | Budesonide EP impurity E (CAS No: 131918-64-4) Or (16α,17-[butylidenebis(oxy)]-11β,21-dihydroxypregna-1,4,14-triene-3,20-dione),Budesonide EP impurity E is an impurity of ,Budesonide, which is a corticosteroid with mainly glucocorticoid activity. used for the management of asthma and various skin disorders. |
| References | Sci-Hub | Pitfalls and success of experimental design in the development of a mixed MEKC method for the analysis of budesonide and its impurities | 10.1002/elps.200800626. (2021). Retrieved December 29, 2021, from Sci-hub.ee website: https://sci-hub.ee/https://doi.org/10.1002/elps.200800626 |
